• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病的代谢组学特征:一项范围综述

Metabolome Features of COPD: A Scoping Review.

作者信息

Godbole Suneeta, Bowler Russell P

机构信息

Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA.

Division of Medicine, National Jewish Health, Denver, CO 80206, USA.

出版信息

Metabolites. 2022 Jul 5;12(7):621. doi: 10.3390/metabo12070621.

DOI:10.3390/metabo12070621
PMID:35888745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9324381/
Abstract

Chronic obstructive pulmonary disease (COPD) is a complex heterogeneous disease state with multiple phenotypic presentations that include chronic bronchitis and emphysema. Although COPD is a lung disease, it has systemic manifestations that are associated with a dysregulated metabolome in extrapulmonary compartments (e.g., blood and urine). In this scoping review of the COPD metabolomics literature, we identified 37 publications with a primary metabolomics investigation of COPD phenotypes in human subjects through Google Scholar, PubMed, and Web of Science databases. These studies consistently identified a dysregulation of the TCA cycle, carnitines, sphingolipids, and branched-chain amino acids. Many of the COPD metabolome pathways are confounded by age and sex. The effects of COPD in young versus old and male versus female need further focused investigations. There are also few studies of the metabolome's association with COPD progression, and it is unclear whether the markers of disease and disease severity are also important predictors of disease progression.

摘要

慢性阻塞性肺疾病(COPD)是一种复杂的异质性疾病状态,具有多种表型表现,包括慢性支气管炎和肺气肿。虽然COPD是一种肺部疾病,但它具有全身表现,与肺外腔室(如血液和尿液)中代谢组失调有关。在本次对COPD代谢组学文献的范围综述中,我们通过谷歌学术、PubMed和科学网数据库,确定了37篇对人类受试者COPD表型进行初级代谢组学研究的出版物。这些研究一致发现三羧酸循环、肉碱、鞘脂和支链氨基酸存在失调。许多COPD代谢组途径受到年龄和性别的混淆。COPD在年轻人与老年人以及男性与女性中的影响需要进一步的针对性研究。关于代谢组与COPD进展的关联研究也很少,目前尚不清楚疾病和疾病严重程度的标志物是否也是疾病进展的重要预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/9324381/8386bf8827b9/metabolites-12-00621-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/9324381/36b632be3069/metabolites-12-00621-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/9324381/8386bf8827b9/metabolites-12-00621-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/9324381/36b632be3069/metabolites-12-00621-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9378/9324381/8386bf8827b9/metabolites-12-00621-g002.jpg

相似文献

1
Metabolome Features of COPD: A Scoping Review.慢性阻塞性肺疾病的代谢组学特征:一项范围综述
Metabolites. 2022 Jul 5;12(7):621. doi: 10.3390/metabo12070621.
2
Metabolomics Reveals Dysregulated Sphingolipid and Amino Acid Metabolism Associated with Chronic Obstructive Pulmonary Disease.代谢组学揭示了与慢性阻塞性肺疾病相关的鞘脂和氨基酸代谢失调。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 21;17:2343-2353. doi: 10.2147/COPD.S376714. eCollection 2022.
3
Comparing Heterogenous Phenotypes of Chronic Obstructive Pulmonary Disease: Network Analysis and Penalized Generalized Linear Model.比较慢性阻塞性肺疾病的异质性表型:网络分析和惩罚广义线性模型
Int J Chron Obstruct Pulmon Dis. 2025 Apr 28;20:1267-1277. doi: 10.2147/COPD.S496199. eCollection 2025.
4
Metabolomic Analysis of Respiratory Epithelial Lining Fluid in Patients with Chronic Obstructive Pulmonary Disease-A Systematic Review.代谢组学分析慢性阻塞性肺疾病患者呼吸上皮衬液-系统评价。
Cells. 2023 Mar 8;12(6):833. doi: 10.3390/cells12060833.
5
Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.与慢性阻塞性肺疾病表型相关的血浆鞘脂
Am J Respir Crit Care Med. 2015 Feb 1;191(3):275-84. doi: 10.1164/rccm.201410-1771OC.
6
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.口服流感嗜血杆菌疫苗预防慢性支气管炎和慢性阻塞性肺疾病急性加重
Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD010010. doi: 10.1002/14651858.CD010010.pub3.
7
Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.基于直接进样质谱的肺癌与慢性阻塞性肺疾病代谢组学关系研究。
Biochimie. 2019 Feb;157:111-122. doi: 10.1016/j.biochi.2018.11.007. Epub 2018 Nov 13.
8
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.口服流感嗜血杆菌疫苗预防慢性支气管炎和慢性阻塞性肺疾病急性加重
Cochrane Database Syst Rev. 2014 Sep 9(9):CD010010. doi: 10.1002/14651858.CD010010.pub2.
9
Analysis of sputum microbial flora in chronic obstructive pulmonary disease patients with different phenotypes during acute exacerbations.分析不同表型慢性阻塞性肺疾病急性加重期患者的痰微生物菌群。
Microb Pathog. 2023 Nov;184:106335. doi: 10.1016/j.micpath.2023.106335. Epub 2023 Sep 4.
10
Global metabolome profiling of exhaled breath condensates in male smokers with asthma COPD overlap and prediction of the disease.哮喘-慢性阻塞性肺疾病重叠综合征男性吸烟者呼出气冷凝液的全球代谢组学分析及疾病预测。
Sci Rep. 2021 Aug 17;11(1):16664. doi: 10.1038/s41598-021-96128-7.

引用本文的文献

1
LncRNA IGF2-AS serves as a miR-106b-5p sponge to induce apoptosis and inflammatory reaction of bronchial epithelial cells in COPD.长链非编码RNA IGF2-AS作为miR-106b-5p的海绵,诱导慢性阻塞性肺疾病中支气管上皮细胞的凋亡和炎症反应。
BMC Pulm Med. 2025 Aug 14;25(1):393. doi: 10.1186/s12890-025-03839-y.
2
Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients.代谢组学特征预测临床稳定的慢性阻塞性肺疾病患者的七年死亡率
Int J Mol Sci. 2025 Jul 2;26(13):6373. doi: 10.3390/ijms26136373.
3
Genetic prediction of immune cells, inflammatory proteins, and metabolite-mediated association between gut microbiota and COPD: a Mendelian randomization study.

本文引用的文献

1
Real-time mass spectrometric identification of metabolites characteristic of chronic obstructive pulmonary disease in exhaled breath.呼出气体中慢性阻塞性肺疾病特征性代谢物的实时质谱鉴定
Clin Mass Spectrom. 2018 Feb 8;7:29-35. doi: 10.1016/j.clinms.2018.02.003. eCollection 2018 Jan.
2
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.识别预测 COPD 肺部恶化的痰液生物标志物。
Chest. 2022 May;161(5):1239-1249. doi: 10.1016/j.chest.2021.10.049. Epub 2021 Nov 18.
3
Multi-omics subtyping pipeline for chronic obstructive pulmonary disease.
免疫细胞、炎症蛋白以及肠道微生物群与慢性阻塞性肺疾病之间代谢物介导关联的遗传预测:一项孟德尔随机化研究
Sci Rep. 2025 Jul 1;15(1):21633. doi: 10.1038/s41598-025-05290-9.
4
Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients.慢性阻塞性肺疾病患者的血浆代谢组学特征
Int J Mol Sci. 2025 May 9;26(10):4526. doi: 10.3390/ijms26104526.
5
Metabolic Aging as an Increased Risk for Chronic Obstructive Pulmonary Disease.代谢性衰老作为慢性阻塞性肺疾病的一个风险增加因素
Metabolites. 2024 Nov 21;14(12):647. doi: 10.3390/metabo14120647.
6
The chemical composition of secondary organic aerosols regulates transcriptomic and metabolomic signaling in an epithelial-endothelial in vitro coculture.次生有机气溶胶的化学成分调节上皮-内皮体外共培养物中的转录组学和代谢组学信号。
Part Fibre Toxicol. 2024 Sep 19;21(1):38. doi: 10.1186/s12989-024-00600-x.
7
Exploring the Potential Role of Metabolomics in COPD: A Concise Review.探讨代谢组学在 COPD 中的潜在作用:简要综述。
Cells. 2024 Mar 7;13(6):475. doi: 10.3390/cells13060475.
8
Deciphering the impact of microbial interactions on COPD exacerbation: An in-depth analysis of the lung microbiome.解读微生物相互作用对慢性阻塞性肺疾病急性加重的影响:对肺部微生物组的深入分析。
Heliyon. 2024 Feb 7;10(4):e24775. doi: 10.1016/j.heliyon.2024.e24775. eCollection 2024 Feb 29.
9
Update on metabolomic findings in COPD patients.慢性阻塞性肺疾病(COPD)患者代谢组学研究结果的最新进展。
ERJ Open Res. 2023 Oct 30;9(5). doi: 10.1183/23120541.00180-2023. eCollection 2023 Sep.
10
Benchtop NMR-Based Metabolomics: First Steps for Biomedical Application.基于台式核磁共振的代谢组学:生物医学应用的初步探索。
Metabolites. 2023 Apr 29;13(5):614. doi: 10.3390/metabo13050614.
多组学生物标志物亚分型管道用于慢性阻塞性肺疾病。
PLoS One. 2021 Aug 25;16(8):e0255337. doi: 10.1371/journal.pone.0255337. eCollection 2021.
4
Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD.稳定期 COPD 患者气道中的二十烷类物质和嗜酸性粒细胞炎症。
Int J Chron Obstruct Pulmon Dis. 2021 May 25;16:1415-1424. doi: 10.2147/COPD.S298678. eCollection 2021.
5
Metabolic Fingerprinting Uncovers the Distinction Between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD.代谢指纹图谱揭示了肺结核相关慢性阻塞性肺疾病与吸烟所致慢性阻塞性肺疾病表型之间的差异。
Front Med (Lausanne). 2021 May 14;8:619077. doi: 10.3389/fmed.2021.619077. eCollection 2021.
6
Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules.慢性阻塞性肺疾病的血浆代谢组学特征及基因变异对表型驱动模块的影响
Netw Syst Med. 2020 Dec 1;3(1):159-181. doi: 10.1089/nsm.2020.0009. Epub 2020 Dec 31.
7
Metabolomic profiling of anaerobic and aerobic energy metabolic pathways in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中厌氧和需氧能量代谢途径的代谢组学分析。
Exp Biol Med (Maywood). 2021 Jul;246(14):1586-1596. doi: 10.1177/15353702211008808. Epub 2021 May 6.
8
Metabolomic Profiling Reveals Sex Specific Associations with Chronic Obstructive Pulmonary Disease and Emphysema.代谢组学分析揭示了与慢性阻塞性肺疾病和肺气肿的性别特异性关联。
Metabolites. 2021 Mar 11;11(3):161. doi: 10.3390/metabo11030161.
9
Ceramide and sphingosine-1 phosphate in COPD lungs.慢性阻塞性肺疾病肺部中的神经酰胺和1-磷酸鞘氨醇
Thorax. 2021 Jan 29. doi: 10.1136/thoraxjnl-2020-215892.
10
Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的疾病相关肠道微生物组和代谢组变化。
Nat Commun. 2020 Nov 18;11(1):5886. doi: 10.1038/s41467-020-19701-0.